BCN Biosciences
Pre-clinicalBCN Biosciences is a privately held pharmaceutical company with core competency in oncology drug development. BCN is currently developing novel small molecule drugs in the RAS and Immune Oncology spaces.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $34.4M
About
BCN Biosciences is a privately held pharmaceutical company with core competency in oncology drug development. BCN is currently developing novel small molecule drugs in the RAS and Immune Oncology spaces.
AntibodiesBiologicsSmall Molecules
Funding History
13Total raised:$34.4M
Grant$1.0MAug 15, 2024
Grant$1.0MAug 1, 2023
Series A$20MMar 15, 2021
Grant$300KJun 8, 2020